Heterogeneous network-based drug repurposing for COVID-19
  The Corona Virus Disease 2019 (COVID-19) belongs to human coronaviruses
(HCoVs), which spreads rapidly around the world. Compared with new drug
development, drug repurposing may be the best shortcut for treating COVID-19.
Therefore, we constructed a comprehensive heterogeneous network based on the
HCoVs-related target proteins and use the previously proposed deepDTnet, to
discover potential drug candidates for COVID-19. We obtain high performance in
predicting the possible drugs effective for COVID-19 related proteins. In
summary, this work utilizes a powerful heterogeneous network-based deep
learning method, which may be beneficial to quickly identify candidate
repurposable drugs toward future clinical trials for COVID-19. The code and
data are available at https://github.com/stjin-XMU/HnDR-COVID.
